Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Retained Earnings came in at -$1.4 billion in Q1 2026, down 1090149.61% year-on-year from N/an in Q1 2025, and down 1496019.15% quarter-over-quarter from $94000.0 in Q4 2025.
Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Retained Earnings history runs 10 years deep, the most recent figure standing at -$1.4 billion for Q1 2026.
- On a quarterly basis, Retained Earnings fell 1090149.61% year-over-year to -$1.4 billion in Q1 2026; TTM through Mar 2026 was -$1.4 billion, a 1090149.61% decrease from a year earlier, with the FY2025 full-year figure at $94000.0, up 100.01% from the prior year.
- Retained Earnings declined to -$1.4 billion in Q1 2026 per SRRK's latest filing, from $94000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $555.5 million in Q1 2022 and bottomed at -$1.4 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$329000.0 (2023), against an average of -$382.0 million.
- Across the five-year window, Retained Earnings sank 1256696.83% in 2024 and soared 358.0% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$510.6 million in 2022, then soared by 100.02% to $92000.0 in 2023, then plunged by 1003051.09% to -$922.7 million in 2024, then jumped by 100.01% to $94000.0 in 2025, then plunged by 1496019.15% to -$1.4 billion in 2026.
- Per Business Quant, the three latest SRRK Retained Earnings figures stand at -$1.4 billion (Q1 2026), $94000.0 (Q4 2025), and -$1.2 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | -1.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.41 Bn |
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | -1.21 Bn |
| Jun 30, 2025 | -1.11 Bn |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | -922.72 Mn |
| Sep 30, 2024 | 128,000.00 |
| Jun 30, 2024 | -791.78 Mn |
| Mar 31, 2024 | -50,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | -630.30 Mn |
| Jun 30, 2023 | -63,000.00 |
| Mar 31, 2023 | -329,000.00 |
| Dec 31, 2022 | -510.63 Mn |
| Sep 30, 2022 | -471.38 Mn |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | 555.51 Mn |
| Dec 31, 2021 | 548.20 Mn |
| Sep 30, 2021 | 527.44 Mn |
| Jun 30, 2021 | 519.32 Mn |